VENCLEXTA 100 MG 120 TABS

Venclexta is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with or without 17p deletion who have received at least one prior therapy. All venclexta dose regimens begin with a 5-week ramp-up. The recommended dose of venclexta is 400 mg once daily after the patient has completed the 5-week dose ramp-up schedule. Venclexta should be taken orally once daily until disease progression or unacceptable toxicity is observed.